TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States

Laura Batti1, Mayya Sundukova1, Emanuele Murana2

  • 1EMBL Mouse Biology Unit, Via Ramarini 32, Monterotondo 00015, Italy.

Cell Reports
|June 23, 2016
PubMed

Insights

TMEM16F protein in spinal microglia is crucial for neuropathic pain development. Its absence prevents pain hypersensitivity by impairing microglial function and phagocytosis.

Area of Science:

  • Neuroscience
  • Immunology

Background:

  • Neuropathic pain is a chronic pain state caused by nervous system injury.
  • Spinal microglia contribute to neuropathic pain via growth factors and cytokines.

Purpose of the Study:

  • Investigate the role of TMEM16F in microglial activity during neuropathic pain.
  • Determine TMEM16F's function as a Ca(2+)-dependent ion channel and phospholipid scramblase in microglia.

Main Methods:

  • Used conditional knockout mice lacking TMEM16F in microglia.
  • Assessed mechanical hypersensitivity, microglial process motility, and phagocytosis post-nerve injury.
  • Monitored GABA immunoreactivity changes.

Main Results:

  • Mice lacking TMEM16F in microglia did not develop mechanical hypersensitivity.
  • TMEM16F deficiency impaired microglial process motility and phagocytosis.
  • Loss of GABA immunoreactivity was prevented in TMEM16F knockout mice.

Conclusions:

  • TMEM16F is essential for the microglial response to nerve injury.
  • Microglial phagocytosis mediated by TMEM16F is critical in neuropathic pain pathogenesis.